Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2001; 11(3):251-65.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.